JP2002513761A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002513761A5 JP2002513761A5 JP2000546777A JP2000546777A JP2002513761A5 JP 2002513761 A5 JP2002513761 A5 JP 2002513761A5 JP 2000546777 A JP2000546777 A JP 2000546777A JP 2000546777 A JP2000546777 A JP 2000546777A JP 2002513761 A5 JP2002513761 A5 JP 2002513761A5
- Authority
- JP
- Japan
- Prior art keywords
- dioxoethyl
- spla
- overproduction
- phenylmethyl
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 2
- FBGWHCFPQBQYNU-UHFFFAOYSA-N 2-(1-benzyl-2-methyl-3-oxamoylindol-4-yl)oxyacetic acid Chemical compound CC1=C(C(=O)C(N)=O)C2=C(OCC(O)=O)C=CC=C2N1CC1=CC=CC=C1 FBGWHCFPQBQYNU-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8387398P | 1998-05-01 | 1998-05-01 | |
| US60/083,873 | 1998-05-01 | ||
| PCT/US1999/008538 WO1999056752A1 (en) | 1998-05-01 | 1999-04-20 | sPLA2 INHIBITOR ESTER |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002513761A JP2002513761A (ja) | 2002-05-14 |
| JP2002513761A5 true JP2002513761A5 (cg-RX-API-DMAC10.html) | 2006-06-22 |
| JP4459441B2 JP4459441B2 (ja) | 2010-04-28 |
Family
ID=22181214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000546777A Expired - Fee Related JP4459441B2 (ja) | 1998-05-01 | 1999-04-20 | sPLA2阻害剤エステル |
Country Status (22)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140327A (en) * | 1999-05-12 | 2000-10-31 | Eli Lilly And Company | Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor |
| WO2001044185A1 (en) * | 1999-12-16 | 2001-06-21 | Eli Lilly And Company | Carbon monoxide-based synthesis of spla2 inhibitors |
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| CN1450893A (zh) * | 2000-07-14 | 2003-10-22 | 伊莱利利公司 | 治疗脓毒症的方法 |
| EP2154958A4 (en) * | 2007-05-03 | 2011-05-04 | Anthera Pharmaceuticals Inc | TREATMENT OF HEART CIRCULATION DISEASES AND DYSLIPIDEMIA WITH INHIBITORS OF SECRETARY PHOSPHOLIPASE A2 (SPLA2) AND SPLA2 HEMMER COMBINATION THERAPIES |
| US8048880B2 (en) | 2007-05-03 | 2011-11-01 | Anthera Pharmaceuticals, Inc. | Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies |
| US20150335498A1 (en) * | 2014-05-22 | 2015-11-26 | The Procter & Gamble Company | Heterogenous mass containing foam |
| US10729600B2 (en) | 2015-06-30 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
| PL3370664T3 (pl) | 2015-11-04 | 2022-03-07 | The Procter & Gamble Company | Wyrób chłonny zawierający strukturę chłonną |
| WO2017079599A1 (en) | 2015-11-04 | 2017-05-11 | The Procter & Gamble Company | Absorbent structure |
| WO2017079605A1 (en) | 2015-11-04 | 2017-05-11 | The Procter & Gamble Company | Method for determining bunch compression |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2036307C (en) * | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
| EP1950200B1 (en) * | 1994-04-01 | 2012-01-11 | Eli Lilly And Company | [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| DE4435477A1 (de) * | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| US6297269B1 (en) * | 1995-06-06 | 2001-10-02 | Pfizer Inc. | Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| CA2358492A1 (en) * | 1998-12-21 | 2000-06-29 | Eli Lilly And Company | Combination therapy for the treatment of sepsis |
-
1999
- 1999-04-20 ID IDW20002216A patent/ID27812A/id unknown
- 1999-04-20 JP JP2000546777A patent/JP4459441B2/ja not_active Expired - Fee Related
- 1999-04-20 KR KR1020007012114A patent/KR20010071197A/ko not_active Withdrawn
- 1999-04-20 CN CN99805672A patent/CN1303290A/zh active Pending
- 1999-04-20 HR HR20000738A patent/HRP20000738A2/hr not_active Application Discontinuation
- 1999-04-20 DE DE69921314T patent/DE69921314T2/de not_active Expired - Lifetime
- 1999-04-20 SK SK1633-2000A patent/SK16332000A3/sk unknown
- 1999-04-20 WO PCT/US1999/008538 patent/WO1999056752A1/en not_active Ceased
- 1999-04-20 BR BR9910149-1A patent/BR9910149A/pt not_active IP Right Cessation
- 1999-04-20 AU AU36525/99A patent/AU755901B2/en not_active Ceased
- 1999-04-20 PL PL99344571A patent/PL344571A1/xx not_active IP Right Cessation
- 1999-04-20 TR TR2000/03198T patent/TR200003198T2/xx unknown
- 1999-04-20 ES ES99918666T patent/ES2230847T3/es not_active Expired - Lifetime
- 1999-04-20 AT AT99918666T patent/ATE280155T1/de not_active IP Right Cessation
- 1999-04-20 CA CA002331036A patent/CA2331036A1/en not_active Abandoned
- 1999-04-20 EP EP99918666A patent/EP1073440B1/en not_active Expired - Lifetime
- 1999-04-20 NZ NZ507391A patent/NZ507391A/en unknown
- 1999-04-20 HU HU0201636A patent/HUP0201636A1/hu unknown
- 1999-04-20 IL IL13920399A patent/IL139203A0/xx unknown
- 1999-04-20 EA EA200001141A patent/EA003277B1/ru not_active IP Right Cessation
-
2000
- 2000-10-10 ZA ZA200005561A patent/ZA200005561B/en unknown
- 2000-10-31 NO NO20005477A patent/NO315940B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001520998A5 (cg-RX-API-DMAC10.html) | ||
| DK1950200T3 (da) | [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-11H-INDOL-4-YL]OXY]EDDIKESYREMETHYLESTER SOM sPLA2-INHIBITOR | |
| JP2002518502A5 (cg-RX-API-DMAC10.html) | ||
| CA2445145A1 (en) | Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes | |
| ATE293443T1 (de) | Medikament zur behandlung chronisch obstruktiver lungenerkrankung | |
| NO20071577L (no) | Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer | |
| JP2002501025A5 (cg-RX-API-DMAC10.html) | ||
| JP2008518890A5 (cg-RX-API-DMAC10.html) | ||
| CA2472954A1 (en) | Aza-arylpiperazines | |
| JP2003503449A5 (cg-RX-API-DMAC10.html) | ||
| PL377478A1 (pl) | Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne | |
| WO2001000566A3 (en) | Substituted phenoxyacetic acids | |
| JP2002520286A5 (cg-RX-API-DMAC10.html) | ||
| JP2001520991A5 (cg-RX-API-DMAC10.html) | ||
| HUP0102812A3 (en) | Pharmaceutical compositions containing the phospholipase inhibitor sodium {[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1h-indol-4-yl]oxy}acetate and process for pruducing them | |
| NO20005477L (no) | sPLA2-hemmende ester | |
| JP2008514558A5 (cg-RX-API-DMAC10.html) | ||
| WO2001019819A3 (en) | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment | |
| EP1253139A3 (en) | Multioligoanilinated fullerenes | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| EP1226819A4 (en) | INHIBITORS FOR THE 20-HETE-PRODUCING ENZYME | |
| JP2001294524A5 (cg-RX-API-DMAC10.html) | ||
| WO2006033505A8 (en) | Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives | |
| AU2129800A (en) | Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation | |
| AU3606100A (en) | Methods for administering pharmacologically active compounds to vertebrates |